Oral anticoagulation in patients with gastrointestinal bleeding and new‐onset atrial fibrillation: A population‐based registry‐linkage study
Prior and concurrent GIB is common among patients with new-onset AF, and despite the overall increasing use of OACs, they remain less utilized in patients with GIB.
Authors
- Konsta Teppo (ORCID: https://orcid.org/0000-0002-4460-0994)
- Juhani K.E. Airaksinen (ORCID: https://orcid.org/0000-0002-0193-568X)
- Juha E.K. Hartikainen (ORCID: https://orcid.org/0000-0003-0847-107X)
- Aapo L. Aro (ORCID: https://orcid.org/0000-0001-7030-6740)
- Santeri Jolkkonen (ORCID: https://orcid.org/0000-0002-4331-2616)
- Jussi Jaakkola (ORCID: https://orcid.org/0000-0002-3398-4283)
- Olli Halminen (ORCID: https://orcid.org/0000-0001-9266-8435)
- Jari K. Haukka (ORCID: https://orcid.org/0000-0003-1450-6208)
- Mika Lehto (ORCID: https://orcid.org/0000-0002-8691-5142)
- Ossi Lehtonen (ORCID: https://orcid.org/0009-0009-4914-1027)
- Miika Linna (ORCID: https://orcid.org/0000-0003-2237-6933)
- P Mustonen (ORCID: https://orcid.org/0009-0004-1472-0946)
- Jukka Putaala
Institutions
- University of Helsinki (FI)
- University of Turku (FI)
- University of Eastern Finland (FI)
- Satakunta University of Applied Sciences (FI)
- Helsinki University Hospital (FI)
- Jorvi Hospital (FI)
- Turku University Hospital (FI)
- Kuopio University Hospital (FI)
- Satakunta Central Hospital (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
- Hospital District of Helsinki and Uusimaa (FI)
- Aalto University (FI)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1111/joim.70018
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Pfizer
- Sanofi
- Foundation for Cardiovascular Research
- Helsingin Yliopisto
- Suomen Lääketieteen Säätiö
- Yrjö Jahnssonin Säätiö
- Aarne Koskelon Säätiö
- Novo Nordisk
- Sydäntutkimussäätiö
- Aarne ja Aili Turusen Säätiö